Clearance Summary
NMI ANTEGRAD CARDIOPLEGIA CANNULA received FDA 510(k) clearance under submission number K961180, sponsored by Naltiac Medical, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 1996-06-21.
- Submission: K961180
- Applicant / Sponsor: Naltiac Medical, Inc.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.4210
- Decision date: 1996-06-21
Classification & Regulation
This clearance is catalogued under FDA product code DWF and 21 CFR 870.4210, within the Cardiovascular review panel as a Class II device.